Literature DB >> 23752073

Correlations of plasma citrulline levels with clinical and endoscopic score and blood markers according to small bowel involvement in pediatric Crohn disease.

Eun Hye Lee1, Jae Sung Ko, Jeong Kee Seo.   

Abstract

OBJECTIVE: Several studies have indicated that plasma citrulline levels reflect the extent of mucosal injury of the small intestine. This study was performed to determine whether plasma citrulline levels correlate with the disease activity in pediatric patients with Crohn disease (CD).
METHODS: A total of 63 CD and 23 ulcerative colitis (UC) patients were included in this study. Disease severity was assessed by pediatric CD activity index (PCDAI), pediatric UC activity index, simplified endoscopic activity score for CD, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR). The correlations among these variables and plasma citrulline levels were evaluated. We performed subgroup analysis whether correlations between plasma citrulline levels and disease activity depend on small bowel involvement in patients with CD.
RESULTS: The plasma citrulline levels correlated negatively with CRP (r = -0.332, P = 0.008), ESR (r = -0.290, P = 0.022), and PCDAI (r = -0.424, P = 0.001) in patients with CD. The plasma citrulline levels were significantly lower in patients with jejunal involvement than in those without (P = 0.027). In subgroup analysis, patients with CD with jejunal involvement showed significantly negative correlations of plasma citrulline levels with CRP (r = -0.628, P = 0.016) and PCDAI (r = -0.632, P = 0.015); however, patients with CD without jejunal involvement revealed no correlations of plasma citrulline levels with CRP and PCDAI. There were no significant correlations between plasma citrulline levels and simplified endoscopic activity score for CD. There were no significant correlations of plasma citrulline levels with CRP, ESR, and pediatric UC activity index in patients with UC.
CONCLUSIONS: Plasma citrulline levels correlated with disease severity as measured by PCDAI, CRP, and ESR in pediatric patients with CD with jejunal involvement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23752073     DOI: 10.1097/MPG.0b013e31829e264e

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  3 in total

1.  Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.

Authors:  Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-06       Impact factor: 2.839

2.  Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways.

Authors:  Merriline M Satyamitra; Andrea L DiCarlo; Brynn A Hollingsworth; Thomas A Winters; Lanyn P Taliaferro
Journal:  Radiat Res       Date:  2022-05-01       Impact factor: 3.372

3.  Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission.

Authors:  Tadakazu Hisamatsu; Nobukazu Ono; Akira Imaizumi; Maiko Mori; Hiroaki Suzuki; Michihide Uo; Masaki Hashimoto; Makoto Naganuma; Katsuyoshi Matsuoka; Shinta Mizuno; Mina T Kitazume; Tomoharu Yajima; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi; Takanori Kanai
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.